Research projects in progress
Novel therapies in pediatric neurodegeneration with energy metabolism dysfunction: MENCIA LAB.
The growing incidence of neurodegenerative diseases represents a huge challenge, and their understanding requires multidisciplinary approaches. …
Development of alternative therapies for the treatment of combined oxidative phosphorylation deficiency Type 1 (COXPD1) caused by mutations in GFM1.
The MGD group studies regulation in diseases in a broad context, ranging from inherited diseases to those related to aging…..
Development of new gene therapy strategies to treat mitochondrial diseases
Hepatoencephalopathy due to the combined deficiency of oxidative phosphorylation type 1 (COXPD1) is caused by mutations in the nuclear gene GFM1…
Mitocure project 2018
Las enfermedades mitocondriales abarcan un amplio espectro de trastornos musculares y neurodegenerativos, crónicos y progresivos, causadas por mutaciones en el ADN nuclear…
Creation of an animal model
Creation of a knockin mouse for a mutation in the GFM1 gene as a study model of hepatic encephalopathy caused by dysfunction of the mitochondrial elongation factor G1…